Shao YS, Xie M, Lu R. Efficacy of cilansetron combined with pivirium bromide in treatment of elderly patients with irritable bowel syndrome.
Shijie Huaren Xiaohua Zazhi 2022;
30:458-464. [DOI:
10.11569/wcjd.v30.i10.458]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
BACKGROUND
Piveronium bromide and other symptomatic treatments are mainly used in the treatment of irritable bowel syndrome (IBS), which can block the volt-dependent calcium channel of gastrointestinal smooth muscle to promote the recovery of normal intestinal motility and control the symptoms of IBS. At present, there are few reports on the efficacy of piveronium bromide combined with cilansetron in the treatment of IBS.
AIM
To evaluate the efficacy of cilansetron combined with pivirium bromide in the treatment of elderly patients with IBS.
METHODS
From June 2017 to June 2019, 126 elderly IBS patients treated at our hospital were selected and randomly randomized into three groups with 42 cases each. Group A was given pinaverium bromide, group B was given cilansetron, and the combination group was given pinaverium bromide + cilansetron. The efficacy and adverse reactions of the three groups were recorded. Gastrointestinal symptoms, intestinal flora, and intestinal barrier function [D-lactic acid, diamine oxidase (DAO), and endotoxin], and gastrointestinal hormone indicators [5-hydroxytryptophan (5-HT), cholecystokinin (CCK), and vasoactive intestinal peptide (VIP)] were compared before and after treatment.
RESULTS
The total effective rate of the combined group was 95.24%, which was higher than those of group A (69.05%) and group B (73.81%) (P < 0.05). After treatment, the scores of diarrhea, abdominal pain, nausea, and vomiting in the combined group were lower than those of groups A and B (P < 0.05). The number of enterococci in the combined group and group B was lower than that before treatment, and the number of bacteroides, lactobacillus, and bifidobacterium was higher than that before treatment (P < 0.05). The levels of D-lactic acid, DAO, and endotoxin in the combined group were lower than those in groups A and B (P < 0.05). The serum levels of 5-HT, CCK, and VIP in the combined group were lower than those of group A and group B (P < 0.05). The incidence of adverse reactions in the three groups was not significantly different (P > 0.05).
CONCLUSION
Both cilansetron and pinaverium bromide can regulate the intestinal flora in elderly patients with IBS; however, cilansetron plus pinaverium bromide in the treatment of elderly IBS patients can further improve the efficacy, reduce gastrointestinal symptoms, repair damaged intestinal barrier function, and decrease gastrointestinal hormone levels.
Collapse